Circulating adhesion molecules as prognostic factors for cutaneous melanoma

This publication has 10 references indexed in Scilit:

• CD44 variant exon epitopes in primary breast cancer and length of survival
  The Lancet, 1995
• Association With Clinical Outcome of Expression of VLA-4 in Primary Cutaneous Malignant Melanoma as Well as P-selection and E-selectin on Intratumoral Vessels
  JNCI Journal of the National Cancer Institute, 1995
• Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers [see comments]
  Blood, 1994
• Soluble intercellular adhesion molecule-1 in serum in chronic hepatitis B and C
  The Esophagus, 1994
• Expression of platelet‐endothelial cell adhesion molecule‐1 (PECAM‐1) during melanoma‐induced angiogenesis in vivo
  Journal of Cutaneous Pathology, 1993
• Expression and function of the CD44 glycoprotein in melanoma cell lines
  Melanoma Research, 1993
• Effects of systemic interferon-α (IFN-α) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852
  Melanoma Research, 1993
• Endothelial expression of intercellular adhesion molecule (ICAM-1) is unaffected by marrow aplasia-inducing chemotherapy
  Journal of Cutaneous Pathology, 1991
• PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene Superfamily
  Science, 1990
• De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.
  Proceedings of the National Academy of Sciences, 1989